JP Morgan Initiates Coverage On Precigen with Neutral Rating
Portfolio Pulse from richadhand@benzinga.com
JP Morgan analyst Brian Cheng initiates coverage on Precigen (NASDAQ:PGEN) with a Neutral rating.

May 23, 2023 | 1:38 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan analyst Brian Cheng initiates coverage on Precigen with a Neutral rating.
The initiation of coverage by JP Morgan analyst Brian Cheng with a Neutral rating indicates that the stock is fairly valued at its current price. This rating is unlikely to have a significant short-term impact on the stock price, as it does not suggest a strong buy or sell signal. However, it may attract some investor attention due to the reputation of JP Morgan.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100